Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.15 $106,020 - $245,100
114,000 New
114,000 $159,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.62 $102,321 - $288,775
37,897 New
37,897 $130,000
Q1 2022

May 16, 2022

SELL
$6.3 - $8.84 $121,986 - $171,168
-19,363 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$6.02 - $11.43 $116,565 - $221,319
19,363 New
19,363 $161,000
Q3 2021

Nov 15, 2021

SELL
$5.46 - $22.6 $78,394 - $324,490
-14,358 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$18.46 - $24.36 $2.36 Million - $3.12 Million
-128,024 Reduced 89.92%
14,358 $342,000
Q1 2021

May 17, 2021

BUY
$17.66 - $28.92 $11,832 - $19,376
670 Added 0.47%
142,382 $2.93 Million
Q4 2020

Feb 16, 2021

BUY
$23.25 - $37.73 $747,999 - $1.21 Million
32,172 Added 29.37%
141,712 $3.47 Million
Q3 2020

Nov 16, 2020

SELL
$3.74 - $28.74 $33,936 - $260,786
-9,074 Reduced 7.65%
109,540 $3.1 Million
Q2 2020

Aug 14, 2020

BUY
$3.04 - $6.2 $197,542 - $402,882
64,981 Added 121.16%
118,614 $565,000
Q1 2020

May 15, 2020

SELL
$2.64 - $3.82 $574,606 - $831,438
-217,654 Reduced 80.23%
53,633 $191,000
Q4 2019

Feb 14, 2020

BUY
$2.99 - $4.42 $651,183 - $962,618
217,787 Added 407.08%
271,287 $936,000
Q3 2019

Nov 14, 2019

BUY
$2.29 - $4.16 $122,515 - $222,560
53,500 New
53,500 $215,000
Q3 2018

Nov 14, 2018

SELL
$7.33 - $9.23 $100,281 - $126,275
-13,681 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$6.91 - $9.55 $94,535 - $130,653
13,681 New
13,681 $118,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.